LGND: Ligand Pharmaceuticals Incorporated

LGND News

• 14:05 Ligand Pharmaceuticals stock hits 52-week high at 161.93 USD
• 11:41 Ligand Pharma stock price target raised to $206 from $157 at H.C. Wainwright
• 17:39 Ligand Pharmaceuticals stock hits 52-week high at $157.54
• 10:18 Orchestra BioMed stock rating downgraded to Neutral from Buy by BTIG
• 06:42 Ligand Q1 2025 slides: Revenue surges 46%, strategic Pelthos merger announced
• 20:04 Ligand Pharmaceuticals completes $460 million convertible notes offering
• 03:52 Ligand Pharmaceuticals prices $400 million convertible notes offering
• 11:08 Ligand Pharmaceuticals plans $400 million convertible notes offering
• 13:47 Ligand Pharma stock price target raised to $185 from $155 at RBC Capital
• 19:23 Ligand Pharma stock price target raised to $167 by Oppenheimer on strong royalty growth
• 13:10 Ligand (LGND) Q2 Revenue Jumps 15%
• 11:27 Ligand Q2 2025 presentation: 57% royalty growth drives raised guidance
• 20:01 Ligand Pharmaceuticals stock hits 52-week high at 143.31 USD
• 21:58 Stock Market Week Ahead: Caterpillar, Palantir And Black Hat Week
• 23:32 Orchestra BioMed secures $70 million from Ligand and Medtronic
• 11:25 Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth
• 12:24 Stifel reiterates Buy rating on Ligand Pharma stock at $143 price target
• 07:00 Ligand Pharmaceuticals Stock Earns 84 RS Rating
• 14:46 Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD
• 22:20 Ligand Pharmaceuticals director Kozarich sells $116k in stock
• 12:13 Why Is Pelthos Therapeutics Stock Trading Higher Thursday - Pelthos Therapeutics (AMEX:PTHS)
• 12:06 Ligand earns $5 million milestone as partner launches molluscum treatment
• 15:06 Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday - First Majestic Silver (NYSE:AG), AES (NYSE:AES)
• 11:05 Ligand completes merger, Pelthos to launch molluscum treatment